Has Christopher Woods, MD received payments from drug or device companies?

Yes. Drug and device makers reported $26,049 in general payments to Christopher Woods, MD across 154 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Christopher Woods, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Christopher Woods, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Christopher Woods, MD

Clinical Cardiac Electrophysiology · Burlingame, CANPI 1740460088

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (53.8%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Biosense Webster, Inc. at 42.9% of the total. Reporting peaked in 2023 at $14,685 and has fallen 82.2% since, to $2,616 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in CA, where the typical reported total is $26,911.

$26,049in general payments, 2019–2025

Across 154 payments — averaging $169.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Biosense Webster, Inc.$11K
Abbott$7K
Atricure, Inc.$5K
Zywie, Inc.$1K
Medtronic$645
Biotronik Inc.$621
plus $491 from 4 others

$1,180,872in research payments, 2019–2025

Across 474 payments — averaging $2491.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Boston Scientific$363K
Kardium Inc.$309K
Abbott$302K
Atricure, Inc.$143K
Biosense Webster, Inc.$64K

What the payments were for

Consulting fees$4,70018%
Travel & lodging$14,01254%
Food & beverage$7,33728%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Biosense Webster, Inc.	15	$11,180
Abbott	76	$7,123
Atricure, Inc.	39	$4,890
Zywie, Inc.	1	$1,100
Medtronic(2 entities)	8	$645
Biotronik Inc.	4	$621
Boston Scientific	7	$399
Baxter Healthcare	2	$54
Impulse Dynamics (USA) Inc.	1	$31
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$6

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Carto 3$6,797
EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$3,531
ENSITE PRECISION$3,014
ENSITE$1,279
EnSite Precision Cardiac Mapping System$970
ATRICLIP LAA EXCLUSION SYSTEM$489
ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM$354
SelectSecure$278
Edora$159
BioMonitor$159
Solia$159
Acticor$159
Rivacor$159
GALLANT$147
Ensite Cardiac Mapping System$139
RhythmVIEW Work Stations$134
WATCHMAN FLX$111

How this compares

$26,049 in reported general payments places this provider in the 45th percentile of 290 clinical cardiac electrophysiology providers in California.

See all clinical cardiac electrophysiology providers in California →

Medicare billing

Part B allowed, 2024

$310,192

Medicare patients

449

Services billed

1,900

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	99	$119,842
MultaqDronedarone Hcl	20	$23,409
Flecainide Acetate	17	$944
Metoprolol Succinate	59	$879
Diltiazem 24hr Er (Cd)Diltiazem Hcl	38	$723
SotalolSotalol Hcl	18	$229
Losartan Potassium	20	$156
Carvedilol	20	$107
Lisinopril	13	$25

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Burlingame

Shephal DoshiSanta Monica$2.1M
Jonathan HsuSan Diego$1.2M
Leslie SaxonLos Angeles$1.1M
Rahul BhardwajLoma Linda$935K
Nicholas Olsonla Jolla$801K
Jonathan DukesVentura$775K
Brett GidneySanta Barbara$756K
John Rogersla Jolla$738K
Rajesh BankerNewport Beach$538K
Rahul DoshiLos Angeles$469K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →